Patents by Inventor Garry L. REDLICH

Garry L. REDLICH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND AGENTS FOR THE TREATMENT OF OCULAR DISEASE
    Publication number: 20240002489
    Abstract: This disclosure relates generally to methods and agents for treating an ocular disease or disorder. More particularly, the present disclosure relates to the use of CD14 antagonist antibodies for treating an ocular disease or disorder.
    Type: Application
    Filed: January 27, 2023
    Publication date: January 4, 2024
    Inventors: Brian W. ZIEGELAAR, Garry L. REDLICH
  • Methods and agents for the treatment of ocular disease
    Patent number: 11618782
    Abstract: This disclosure relates generally to methods and agents for treating an ocular disease or disorder. More particularly, the present disclosure relates to the use of CD14 antagonist antibodies for treating an ocular disease or disorder.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: April 4, 2023
    Assignee: Line 6 Biotechnology, Inc.
    Inventors: Brian W. Ziegelaar, Garry L. Redlich
  • METHODS AND AGENTS FOR THE TREATMENT OF OCULAR DISEASE
    Publication number: 20220220194
    Abstract: This disclosure relates generally to methods and agents for treating an ocular disease or disorder. More particularly, the present disclosure relates to the use of CD14 antagonist antibodies for treating an ocular disease or disorder.
    Type: Application
    Filed: February 23, 2022
    Publication date: July 14, 2022
    Inventors: Brian W. ZIEGELAAR, Garry L. REDLICH